Remove Bone Scan Remove Disease Remove Nuclear Medicine
article thumbnail

Bone scans may be viable for diagnosing calciphylaxis

AuntMinnie

Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bone scans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bone scans in calciphylaxis based on a review of the literature.

Bone Scan 118
article thumbnail

Types of Nuclear Medicine

Independent Imaging

Nuclear medicine is a form of specialty medicine that uses radioactive tracers to evaluate bodily functions and to diagnose and treat a wide range of health conditions. Nuclear scans produce images of the body’s anatomy that cannot be obtained as clearly or fully with other imaging techniques.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

For Some Prostate Cancer Patients, PSMA PET May Be Better for Initial Staging of Disease

UCSF Biomedical Imaging

An article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer.

article thumbnail

SPECT/CT improves management of Pluvicto patients

AuntMinnie

SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted.

article thumbnail

Imaging Tests for Cancer

Capitol Imaging Services

There are several types of imaging tests that physicians use to detect cancer in patients: X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound (US), Nuclear Medicine, and Positron Emission Tomography (PET). Staging and Restaging If cancer is found, it is important to determine how much the cancer has spread.

article thumbnail

PSMA-PET superior to MRI in phase II prostate cancer trial

AuntMinnie

The primary outcome was the correct identification of the prostate cancer tumor stage, which is crucial for surgeons to determine the extent of the disease -- whether it has spread beyond the prostate gland, for instance. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).

MRI 105
article thumbnail

PET tracer shows promise in prostate cancer patients

AuntMinnie

Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. You've hear a lot about PSMA. approved Ga-68 PSMA-PET and experimental Ga-68 RM2.